On July 8, HCA Healthcare declined 3.16% in regular trading, trading at approximately $411.11 per share, with turnover of $98.32 million. The decline came amid sector-wide selling pressure across health care facility stocks.

On the news front, Cantor Fitzgerald on July 7 significantly lowered its price target on HCA Healthcare to $525 from $588, while maintaining an overweight rating. Meanwhile, BofA Securities adjusted its target modestly higher to $435 from $415 on July 8. The consensus mean price target has steadily declined from approximately $547 in mid-April to around $500 currently, reflecting growing caution among Wall Street analysts following softer-than-expected Q1 admission trends due to mild respiratory disease activity and winter storm disruptions.

Within the Health Care Facilities sector, the group broadly declined. Universal Health fell 4.05%, Tenet Healthcare dropped 2.2%, and Encompass Health slipped 1.28%, while Ensign gained 0.53% and PACS Group rose 3.51%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)